{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,27]],"date-time":"2026-04-27T04:49:47Z","timestamp":1777265387079,"version":"3.51.4"},"reference-count":48,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T00:00:00Z","timestamp":1738368000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T00:00:00Z","timestamp":1738368000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,1,13]],"date-time":"2026-01-13T00:00:00Z","timestamp":1768262400000},"content-version":"am","delay-in-days":346,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T00:00:00Z","timestamp":1738368000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T00:00:00Z","timestamp":1738368000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T00:00:00Z","timestamp":1738368000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T00:00:00Z","timestamp":1738368000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T00:00:00Z","timestamp":1738368000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biochemical and Biophysical Research Communications"],"published-print":{"date-parts":[[2025,2]]},"DOI":"10.1016\/j.bbrc.2025.151310","type":"journal-article","created":{"date-parts":[[2025,1,8]],"date-time":"2025-01-08T23:35:05Z","timestamp":1736379305000},"page":"151310","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["Selection of combination adjuvants for enhanced immunogenicity of a recombinant CelTOS vaccine against Plasmodium falciparum"],"prefix":"10.1016","volume":"748","author":[{"given":"Sakineh","family":"Pirahmadi","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mostafa","family":"Zargar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zeinab","family":"Pourhashem","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hediyeh","family":"Vand-Rajabpour","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jafar J.","family":"Sani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hemn","family":"Yousefi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shima","family":"Afzali","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sedigheh","family":"Zakeri","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9502-0407","authenticated-orcid":false,"given":"Akram Abouie","family":"Mehrizi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.bbrc.2025.151310_bib1","author":"Organization"},{"key":"10.1016\/j.bbrc.2025.151310_bib2","doi-asserted-by":"crossref","first-page":"1700","DOI":"10.1016\/S0140-6736(13)62238-2","article-title":"Malaria vaccine technology roadmap","volume":"382","author":"Moorthy","year":"2013","journal-title":"Lancet"},{"key":"10.1016\/j.bbrc.2025.151310_bib3","article-title":"Malaria transmission-blocking vaccines: present status and future perspectives","volume":"vol. 1","author":"Doumbo","year":"2018"},{"key":"10.1016\/j.bbrc.2025.151310_bib4","doi-asserted-by":"crossref","first-page":"5480","DOI":"10.1016\/j.vaccine.2020.06.018","article-title":"Comparison of carrier proteins to conjugate malaria transmission blocking vaccine antigens, Pfs25 and Pfs230","volume":"38","author":"Scaria","year":"2020","journal-title":"Vaccine"},{"key":"10.1016\/j.bbrc.2025.151310_bib5","doi-asserted-by":"crossref","first-page":"1278","DOI":"10.1002\/jps.21523","article-title":"Vaccine adjuvants: current challenges and future approaches","volume":"98","author":"Wilson-Welder","year":"2009","journal-title":"J. Pharm. Sci."},{"key":"10.1016\/j.bbrc.2025.151310_bib6","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/j.coi.2020.08.008","article-title":"New horizons in adjuvants for vaccine development","volume":"65","author":"Reed","year":"2020","journal-title":"Curr. Opin. Immunol."},{"key":"10.1016\/j.bbrc.2025.151310_bib7","doi-asserted-by":"crossref","first-page":"381","DOI":"10.4161\/hv.5.6.8175","article-title":"Potential adjuvantic properties of innate immune stimuli","volume":"5","author":"Warshakoon","year":"2009","journal-title":"Hum. Vaccin."},{"key":"10.1016\/j.bbrc.2025.151310_bib8","doi-asserted-by":"crossref","first-page":"323","DOI":"10.3390\/vaccines2020323","article-title":"Immune adjuvant effect of molecularly-defined toll-like receptor ligands","volume":"2","author":"Toussi","year":"2014","journal-title":"Vaccines (Basel)"},{"key":"10.1016\/j.bbrc.2025.151310_bib9","doi-asserted-by":"crossref","first-page":"320","DOI":"10.3390\/vaccines3020320","article-title":"Vaccine adjuvants: from 1920 to 2015 and beyond","volume":"3","author":"Di Pasquale","year":"2015","journal-title":"Vaccines (Basel)"},{"key":"10.1016\/j.bbrc.2025.151310_bib10","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1038\/s41541-021-00407-3","article-title":"Malaria transmission-blocking conjugate vaccine in ALFQ adjuvant induces durable functional immune responses in rhesus macaques","volume":"6","author":"Scaria","year":"2021","journal-title":"NPJ. Vaccines"},{"key":"10.1016\/j.bbrc.2025.151310_bib11","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1080\/14760584.2017.1276833","article-title":"Towards clinical development of a Pf s48\/45-based transmission blocking malaria vaccine","volume":"16","author":"Theisen","year":"2017","journal-title":"Expert Rev. Vaccines"},{"key":"10.1016\/j.bbrc.2025.151310_bib12","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1016\/j.vaccine.2016.11.072","article-title":"Immunogenicity and malaria transmission reducing potency of Pfs48\/45 and Pfs25 encoded by DNA vaccines administered by intramuscular electroporation","volume":"35","author":"Datta","year":"2017","journal-title":"Vaccine"},{"key":"10.1016\/j.bbrc.2025.151310_bib13","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1038\/s41541-018-0065-5","article-title":"Antibody targeting of a specific region of Pfs47 blocks Plasmodium falciparum malaria transmission","volume":"3","author":"Canepa","year":"2018","journal-title":"NPJ. Vaccines"},{"key":"10.1016\/j.bbrc.2025.151310_bib14","article-title":"N-terminal Pfs230 domain produced in baculovirus as a biological active transmission-blocking vaccine candidate, Clin. Vaccine","volume":"24","author":"Lee","year":"2017","journal-title":"Immunol."},{"key":"10.1016\/j.bbrc.2025.151310_bib15","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1186\/s12936-019-2773-3","article-title":"Cell-traversal protein for ookinetes and sporozoites (CelTOS) formulated with potent TLR adjuvants induces high-affinity antibodies that inhibit Plasmodium falciparum infection in Anopheles stephensi","volume":"18","author":"Pirahmadi","year":"2019","journal-title":"Malar. J."},{"issue":"6","key":"10.1016\/j.bbrc.2025.151310_bib16","doi-asserted-by":"crossref","DOI":"10.1128\/IAI.00911-18","volume":"87","author":"Pirahmadi","year":"2019","journal-title":"Infect. Immun."},{"issue":"8","key":"10.1016\/j.bbrc.2025.151310_bib17","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0012294","article-title":"Immunization with pre-erythrocytic antigen CelTOS from Plasmodium falciparum elicits cross-species protection against heterologous challenge with Plasmodium berghei","volume":"5","author":"Bergmann-Leitner","year":"2010","journal-title":"PLoS One"},{"issue":"10","key":"10.1016\/j.bbrc.2025.151310_bib18","doi-asserted-by":"crossref","first-page":"3709","DOI":"10.1128\/IAI.00180-13","article-title":"Inducing humoral and cellular responses to multiple sporozoite and liver-stage malaria antigens using exogenous plasmid DNA","volume":"81","author":"Ferraro","year":"2013","journal-title":"Infect. Immun."},{"key":"10.1016\/j.bbrc.2025.151310_bib19","doi-asserted-by":"crossref","first-page":"732","DOI":"10.1038\/35099560","article-title":"Recognition of doublestranded RNA and activation of NF-\u03baB by Toll-like receptor 3","volume":"413","author":"Alexopoulou","year":"2001","journal-title":"Nature"},{"issue":"7","key":"10.1016\/j.bbrc.2025.151310_bib20","doi-asserted-by":"crossref","first-page":"1589","DOI":"10.1084\/jem.20090247","article-title":"Dendritic cells require a systemic type I interferon response to mature and induce CD4+ Th1 immunity with poly IC as adjuvant","volume":"206","author":"Longhi","year":"2009","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.bbrc.2025.151310_bib21","doi-asserted-by":"crossref","first-page":"7256","DOI":"10.1016\/j.vaccine.2010.08.098","article-title":"Poly(I:C) is an effective adjuvant for antibody and multifunctional CD4+ T cell responses to Plasmodium falciparum circumsporozoite protein (CSP) and \u03b1DEC-CSP in non human primates","volume":"28","author":"Tewari","year":"2010","journal-title":"Vaccine"},{"key":"10.1016\/j.bbrc.2025.151310_bib22","doi-asserted-by":"crossref","first-page":"6186","DOI":"10.4049\/jimmunol.0901474","article-title":"AS04, an aluminum salt- and TLR4 agonistbased adjuvant system, induces a transient localized innate immune response leading to enhanced adaptive immunity","volume":"183","author":"Didierlaurent","year":"2009","journal-title":"J. Immunol."},{"key":"10.1016\/j.bbrc.2025.151310_bib23","doi-asserted-by":"crossref","first-page":"1001","DOI":"10.1016\/S0264-410X(96)00293-9","article-title":"Induction of cross-reactive cytotoxic Tlymphocyte responses specific for HIV-1 gp120 using saponin adjuvant (QS-21) supplemented subunit vaccine formulations","volume":"15","author":"Newman","year":"1997","journal-title":"Vaccine"},{"key":"10.1016\/j.bbrc.2025.151310_bib24","doi-asserted-by":"crossref","first-page":"2263","DOI":"10.1016\/S0264-410X(02)00115-9","article-title":"Safety, tolerability and immunogenicity of new formulations of the Plasmodium falciparum malaria peptide vaccine SPf66 combined with the immunological adjuvant QS-21","volume":"20","author":"Kashala","year":"2002","journal-title":"Vaccine"},{"key":"10.1016\/j.bbrc.2025.151310_bib25","doi-asserted-by":"crossref","first-page":"4148","DOI":"10.1016\/j.vaccine.2005.03.019","article-title":"Safety and immuno-genicty of RTS,S \u2044 AS02A candidate malaria vaccine in Gambian children","volume":"23","author":"Bojang","year":"2005","journal-title":"Vaccine"},{"key":"10.1016\/j.bbrc.2025.151310_bib26","doi-asserted-by":"crossref","first-page":"603","DOI":"10.4269\/ajtmh.1994.51.603","article-title":"Safety, immunogenicity, and efficacy of a malaria sporozoite vaccine administered with monophosphoryl lipid A, cell wall skeleton of mycobacteria, and squalane as adjuvant","volume":"51","author":"Hoffman","year":"1994","journal-title":"Am. J. Trop. Med. Hyg."},{"key":"10.1016\/j.bbrc.2025.151310_bib27","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1016\/j.actatropica.2018.12.014","volume":"190","author":"Pirahmadi","year":"2019","journal-title":"Acta Trop."},{"issue":"1","key":"10.1016\/j.bbrc.2025.151310_bib28","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/j.molbiopara.2007.04.008","article-title":"Improved synchronous production of Plasmodium falciparum gametocytes in vitro","volume":"154","author":"Fivelman","year":"2007","journal-title":"Mol. Biochem. Parasitol."},{"key":"10.1016\/j.bbrc.2025.151310_bib29","first-page":"37","article-title":"Evidence for environmental modulation of gametocytogenesis in Plasmodium falciparum in continuous culture","volume":"57","author":"Carter","year":"1979","journal-title":"Bull. World Health Organ."},{"issue":"1","key":"10.1016\/j.bbrc.2025.151310_bib30","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1590\/S0074-02762010000100001","article-title":"Transmission blocking vaccines to control insect-borne diseases: a review","volume":"105","author":"Coutinho-Abreu","year":"2010","journal-title":"Mem. Inst. Oswaldo Cruz"},{"key":"10.1016\/j.bbrc.2025.151310_bib31","doi-asserted-by":"crossref","first-page":"176","DOI":"10.3389\/fimmu.2013.00176","article-title":"Self-adjuvanting bacterial vectors expressing pre-erythrocytic antigens induce sterile protection against malaria","volume":"4","author":"Bergmann-Leitner","year":"2013","journal-title":"Front. Immunol."},{"issue":"10","key":"10.1016\/j.bbrc.2025.151310_bib32","doi-asserted-by":"crossref","first-page":"1633","DOI":"10.1128\/CVI.00235-12","article-title":"Effects on immunogenicity by formulations of emulsion-based adjuvants for malaria vaccines","volume":"19","author":"Fox","year":"2012","journal-title":"Clin. Vaccine Immunol."},{"issue":"11","key":"10.1016\/j.bbrc.2025.151310_bib33","doi-asserted-by":"crossref","first-page":"1435","DOI":"10.1002\/biot.201400350","article-title":"Malaria vaccine candidate antigen targeting the pre\u2010erythrocytic stage of Plasmodium falciparum produced at high level in plants","volume":"9","author":"Voepe","year":"2014","journal-title":"Biotechnol. J."},{"key":"10.1016\/j.bbrc.2025.151310_bib34","doi-asserted-by":"crossref","first-page":"843","DOI":"10.3389\/fimmu.2019.00843","article-title":"Poly(I:C) potentiates T cell immunity to a dendritic cell targeted HIV-multi epitope vaccine","volume":"10","author":"Apost\u00f3lico","year":"2019","journal-title":"Front. Immunol."},{"issue":"9","key":"10.1016\/j.bbrc.2025.151310_bib35","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1016\/j.ijpara.2021.01.006","article-title":"A review of combination adjuvants for malaria vaccines: a promising approach for vaccine development","volume":"51","author":"Pirahmadi","year":"2021","journal-title":"Int. J. Parasitol."},{"issue":"12","key":"10.1016\/j.bbrc.2025.151310_bib36","doi-asserted-by":"crossref","first-page":"5939","DOI":"10.1128\/IAI.00846-07","article-title":"Agonists of Toll-like receptors 3, 4, 7, and 9 are candidates for use as adjuvants in an outer membrane vaccine against Neisseria meningitidis serogroup B","volume":"75","author":"Fransen","year":"2007","journal-title":"Infect. Immun."},{"issue":"19","key":"10.1016\/j.bbrc.2025.151310_bib37","doi-asserted-by":"crossref","first-page":"10413","DOI":"10.1128\/JVI.00928-10","article-title":"TLR4 ligands augment antigen-specific CD8+ T lymphocyte responses elicited by a viral vaccine vector","volume":"84","author":"Rhee","year":"2010","journal-title":"J. Virol."},{"issue":"7028","key":"10.1016\/j.bbrc.2025.151310_bib38","doi-asserted-by":"crossref","first-page":"887","DOI":"10.1038\/nature03326","article-title":"Toll-like receptor 3 promotes cross-priming to virus-infected cells","volume":"433","author":"Schulz","year":"2005","journal-title":"Nature"},{"issue":"5","key":"10.1016\/j.bbrc.2025.151310_bib39","doi-asserted-by":"crossref","first-page":"2243","DOI":"10.4049\/jimmunol.0903013","article-title":"Cutting edge: priming of CD8 T cell immunity to herpes simplex virus type 1 requires cognate TLR3 expression in vivo","volume":"184","author":"Davey","year":"2010","journal-title":"J. Immunol."},{"key":"10.1016\/j.bbrc.2025.151310_bib40","doi-asserted-by":"crossref","first-page":"2517","DOI":"10.1016\/S0264-410X(99)00062-6","article-title":"The adjuvant combination monophosphoryl lipid A and QS21 switches T cell responses induced with a soluble recombinant HIV protein from Th2 to Th1","volume":"17","author":"Moore","year":"1999","journal-title":"Vaccine"},{"issue":"12","key":"10.1016\/j.bbrc.2025.151310_bib41","doi-asserted-by":"crossref","first-page":"1787","DOI":"10.1016\/j.vaccine.2009.01.091","article-title":"Advances in saponin-based adjuvants","volume":"27","author":"Sun","year":"2009","journal-title":"Vaccine"},{"issue":"28","key":"10.1016\/j.bbrc.2025.151310_bib42","doi-asserted-by":"crossref","first-page":"14119","DOI":"10.1073\/pnas.1900147116","article-title":"Chemical depletion of phagocytic immune cells in Anopheles gambiae reveals dual roles of mosquito hemocytes in anti-Plasmodium immunity","volume":"116","author":"Kwon","year":"2019","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"issue":"8","key":"10.1016\/j.bbrc.2025.151310_bib43","doi-asserted-by":"crossref","first-page":"3017","DOI":"10.1128\/iai.65.8.3017-3023.1997","article-title":"Complement-mediated lysis of Plasmodium falciparum gametes by malaria-immune human sera is associated with antibodies to the gamete surface antigen Pfs230","volume":"65","author":"Healer","year":"1997","journal-title":"Infect. Immun."},{"issue":"5","key":"10.1016\/j.bbrc.2025.151310_bib44","doi-asserted-by":"crossref","first-page":"1799","DOI":"10.1128\/IAI.02980-14","article-title":"Alga-produced malaria transmission-blocking vaccine candidate Pfs25 formulated with a human use-compatible potent adjuvant induces high-affinity antibodies that block Plasmodium falciparum infection of mosquitoes","volume":"83","author":"Patra","year":"2015","journal-title":"Infect. Immun."},{"issue":"10","key":"10.1016\/j.bbrc.2025.151310_bib45","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1111\/j.1365-3024.1994.tb00305.x","article-title":"Transmission-blocking antibodies against multiple, non-variant target epitopes of the Plasmodium falciparum gamete surface antigen Pfs230 are all complement-fixing","volume":"16","author":"Read","year":"1994","journal-title":"Parasite Immunol."},{"issue":"2","key":"10.1016\/j.bbrc.2025.151310_bib46","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1128\/iai.63.2.467-471.1995","article-title":"Transmission blockade of Plasmodium falciparum malaria by anti-Pfs230-specific antibodies is isotype dependent","volume":"63","author":"Roeffen","year":"1995","journal-title":"Infect. Immun."},{"issue":"2","key":"10.1016\/j.bbrc.2025.151310_bib47","doi-asserted-by":"crossref","first-page":"1164","DOI":"10.4049\/jimmunol.178.2.1164","article-title":"MyD88-dependent and MyD88-independent pathways in synergy, priming, and tolerance between TLR agonists","volume":"178","author":"Bagchi","year":"2007","journal-title":"J. Immunol."},{"issue":"6","key":"10.1016\/j.bbrc.2025.151310_bib48","doi-asserted-by":"crossref","first-page":"443","DOI":"10.3109\/08830185.2014.921164","article-title":"TLR cross-talk confers specificity to innate immunity","volume":"33","author":"Tan","year":"2014","journal-title":"Int. Rev. Immunol."}],"container-title":["Biochemical and Biophysical Research Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006291X25000245?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006291X25000245?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,4,27]],"date-time":"2026-04-27T04:29:19Z","timestamp":1777264159000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0006291X25000245"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,2]]},"references-count":48,"alternative-id":["S0006291X25000245"],"URL":"https:\/\/doi.org\/10.1016\/j.bbrc.2025.151310","relation":{},"ISSN":["0006-291X"],"issn-type":[{"value":"0006-291X","type":"print"}],"subject":[],"published":{"date-parts":[[2025,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Selection of combination adjuvants for enhanced immunogenicity of a recombinant CelTOS vaccine against Plasmodium falciparum","name":"articletitle","label":"Article Title"},{"value":"Biochemical and Biophysical Research Communications","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bbrc.2025.151310","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"151310"}}